104 51. Jensen KB, Kaptchuk TJ, Kirsch I, et al. Nonconscious activation of placebo and nocebo pain responses. Proceedings of the National Academy of Sciences of the United States of America. 2012;109(39):15959-15964. doi:10.1073/pnas.1202056109 52. Logothetis NK, Pauls J, Augath M, Trinath T, Oeltermann A. Neurophysiological investigation of the basis of the fMRI signal. Nature. 2001;412(6843):150-157. doi:10.1038/35084005 53. Huettel SA, Song AW, Mccarthy G. Functional Magnetic Resonance Imaging. 2nd ed. Sinauer Associates, Inc; 2009. 54. Simpson JR, Drevets WC, Snyder AZ, Gusnard DA, Raichle ME. Emotioninduced changes in human medial prefrontal cortex: II. During anticipatory anxiety. Proceedings of the National Academy of Sciences of the United States of America. 2001;98(2):688-693. doi:10.1073/pnas.98.2.688 55. Wager TD, Atlas LY. The neuroscience of placebo effects: connecting context, learning and health. Nature reviews Neuroscience. 2015;16(7):403-418. doi:10.1038/nrn3976 56. Phan KL, Wager T, Taylor SF, Liberzon I. Functional Neuroanatomy of Emotion: A Meta-Analysis of Emotion Activation Studies in PET and fMRI. NeuroImage. 2002;16(2):331-348. doi:10.1006/NIMG.2002.1087 57. Keltner JR. Isolating the Modulatory Effect of Expectation on Pain Transmission: A Functional Magnetic Resonance Imaging Study. Journal of Neuroscience. Published online 2006. doi:10.1523/JNEUROSCI.4463-05.2006 58. Kong J, Jensen K, Loiotile R, et al. Functional connectivity of the frontoparietal network predicts cognitive modulation of pain. PAIN®. 2013;154(3):459467. doi:10.1016/J.PAIN.2012.12.004 59. Jensen K, Kaptchuk TJ, Chen X, et al. A neural mechanism for nonconscious activation of conditioned placebo and nocebo responses. Cerebral Cortex. 2015;25(10):3903-3910. doi:10.1093/cercor/bhu275 60. Rodriguez-Raecke R, Doganci B, Breimhorst M, et al. Insular cortex activity is associated with effects of negative expectation on nociceptive long-term habituation. Journal of Neuroscience. 2010;30(34):11363-11368. doi:10.1523/JNEUROSCI.2197-10.2010 61. Schmid J, Theysohn N, Gaß F, et al. Neural mechanisms mediating positive and negative treatment expectations in visceral pain: A functional magnetic resonance imaging study on placebo and nocebo effects in healthy volunteers. Pain. 2013;154(11):2372-2380. doi:10.1016/j.pain.2013.07.013 62. Geuter S, Buchel C. Facilitation of Pain in the Human Spinal Cord by Nocebo Treatment. Journal of Neuroscience. 2013;33(34):13784-13790. doi:10.1523/JNEUROSCI.2191-13.2013 63. Tinnermann A, Geuter S, Sprenger C, Finsterbusch J, Büchel C. Interactions between brain and spinal cord mediate value effects in nocebo hyperalgesia. Science. 2017;358:105-108. 64. Egorova N, Benedetti F, Gollub RL, Kong J. Between placebo and nocebo: Response to control treatment is mediated by amygdala activity and connectivity. European Journal of Pain (United Kingdom). 2020;24(3):580-592. doi:10.1002/ejp.1510 65. Miller EK. The prefontral cortex and cognitive control. Nature Reviews Neuroscience. 2000;1(1):59-65. doi:10.1038/35036228 66. Greenspan JD, Lee RR, Lenz FA. Pain sensitivity alterations as a function of lesion location in the parasylvian cortex. Pain. 1999;81(3):273-282. doi:10.1016/S03043959(99)00021-4 67. Phelps EA. Human emotion and memory: interactions of the amygdala and hippocampal complex. Current Opinion in Neurobiology. 2004;14(2):198-202. doi:10.1016/J.CONB.2004.03.015
RkJQdWJsaXNoZXIy MTk4NDMw